The NMDA receptor complex

B Scatton - Fundamental & clinical pharmacology, 1993 - Wiley Online Library
The synaptic responses elicited by glutamate and aspartate in the CNS are mediated by
distinct groups of receptors which include the ionotropic NMDA receptor. The NMDA receptor is …

Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease

B Scatton, F Javoy-Agid, L Rouquier, B Dubois, Y Agid - Brain research, 1983 - Elsevier
… and Scatton, B., Determination of 5-hydroxytryptophan, serotonin and 5-hydroxyindoleacetic
acid in rat and human brain and biological fluids by reversed-phase high-performance …

Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity

…, F Gonon, C Carter, J Benavides, B Scatton - … of Pharmacology and …, 1997 - ASPET
The benzamide derivative amisulpride shows a unique therapeutic profile being antipsychotic,
at high doses, and disinhibitory, at low doses, while giving rise to only a low incidence of …

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of …

…, J Wagnon, M Pascal, B Scatton… - Proceedings of the …, 2002 - National Acad Sciences
… For example, the intra-septal application of the mixed V 1a/b receptor antagonist d(CH 2 )
5 Tyr(Et)VAVP was found to produce anxiolytic-like effects in the elevated plus-maze (EPM) …

The gabaergic hypothesis of depression

KG Lloyd, B Zivkovic, B Scatton, PL Morselli… - Progress in Neuro …, 1989 - Elsevier
… perhaps together with B-adrenoceptor mediated events. … of GABAB receptors and the
downregulation of B-adrenergic … and BUSCH, B. (1988) Antidepressant activity of progabide and …

Amisulpride: from animal pharmacology to therapeutic action

B Scatton, Y Claustre, A Cudennec… - International clinical …, 1997 - journals.lww.com
Amisulpride is a benzamide derivative with a unique neurochemical and psychopharmacological
profile. This compound has selective affinity for human dopamine D3 and D2 receptor …

Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity

…, R Depoortere, E Morel, DJ Sanger, B Scatton - … of Pharmacology and …, 1997 - ASPET
Amisulpride, a benzamide derivative, is an antipsychotic drug with a pharmacological profile
distinct from that of classical neuroleptics such as haloperidol and from that of another …

Origin of dopaminergic innervation of the rat hippocampal formation

B Scatton, H Simon, M Le Moal, S Bischoff - Neuroscience letters, 1980 - Elsevier
B: rats received two bilateral microinjections of 6OHDA (2/~g/1 gl) in A9 or A10 areas
with a 3-day interval between injections and were sacrificed 3 weeks after surgery. Sham-operated …

Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats

…, P Soubrié, F Oury-Donat, JP Maffrand, B Scatton… - Hepatology, 2007 - journals.lww.com
This study investigated the effects of rimonabant (SR141716), an antagonist of the cannabinoid
receptor type 1 (CB1), on obesity-associated hepatic steatosis and related features of …

Autoradiographic distribution of the D1 agonist [3H] SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors

A Dubois, M Savasta, O Curet, B Scatton - Neuroscience, 1986 - Elsevier
The regional distribution of the specific D 1 agonist [ 3 H]SKF 38393 (SKF 38393, 2,3,4,5-tetra-hydro-7,
8-dihydroxy-1-phenyl-1H-3-benzazepine) has been studied autoradiographically …